+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 19Years +
All Genders
Healthy Volunteers
ID07030348

Study to Find Early Pancreatic Cancer Biomarkers Using Duodenal Fluid Collected by Endoscopy

Led by Do Hyun Park · Updated on 2025-06-22

263

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Pancreatic cancer is a leading cause of cancer-related deaths in the United States, with a low five-year survival rate of 11%. Only a small portion of patients are eligible for surgery due to the disease stage. This research aims to improve early diagnosis by identifying biomarkers in duodenal pancreatic fluid, which is easier to collect during an endoscopy, addressing the unmet need for better early detection methods. The study involves two groups one with confirmed or suspected pancreatic ductal adenocarcinoma PDAC and another with pancreatic cystic tumors, pancreatitis, or no pancreatic disease. Duodenal fluid samples will be collected during medically necessary endoscopic procedures such as upper endoscopy, endoscopic ultrasound, or ERCP. Researchers will analyze these samples to discover biomarkers linked to early pancreatic cancer. Participants will undergo endoscopy-related procedures as part of their medical care, during which duodenal fluid will be collected for analysis. The primary outcome focuses on identifying biomarkers within one year from the baseline, with a secondary goal of validating findings using samples from the U.S. Participants are monitored for up to two years, and data collected will help understand early signs of pancreatic cancer for potential future diagnostic use.

CONDITIONS

Brief Title

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

Research Team

H

HyeJin Song, CRC

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here